ACTN2 (Alpha-actinin-2) variants and mutations
ACTN2 (also known as Alpha-actinin-2) is a human protein-coding gene encoding an alpha-actinin-2 protein. It crosslinks actin at the sarcomeric Z-disc and organizes mechanical and signaling complexes in cardiac and skeletal muscle. Pathogenic variants can cause hypertrophic, dilated, or other inherited cardiomyopathies and occasional skeletal-muscle phenotypes. This analysis covers 1,713 ACTN2 variants and mutations. Of these, 71% have computational variant effect predictions. Disease context includes dilated cardiomyopathy 1AA, myopathy, congenital, with structured cores and z-line abnormalities, and Rare familial disorder with hypertrophic cardiomyopathy. Example ACTN2 variants include M1V, N2I, and N2K.
Variant analysis overview
- Gene: ACTN2
- Protein: Alpha-actinin-2
- UniProt accession: P35609
- Organism: Homo sapiens
- Variants analyzed: 1713
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 1,501 unspecified-consequence records; 114 missense variants; 72 synonymous variants; 10 stop-gained variants; 11 frameshift variants; 2 in-frame deletions; 1 splice-region variants; 2 substitution
- Prediction scores: 1,219 variants have prediction scores (71% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: dilated cardiomyopathy 1AA, myopathy, congenital, with structured cores and z-line abnormalities, Rare familial disorder with hypertrophic cardiomyopathy, autosomal dominant dilated cardiomyopathy, neurodegenerative disease, cardiomyopathy, familial hypertrophic, 23, with or without ventricular noncompac, intrinsic cardiomyopathy, myopathy, distal, 6, adult-onset, autosomal dominant, familial hypertrophic cardiomyopathy, ACTN2-related cardiac and skeletal myopathy, heart failure, hypertrophic cardiomyopathy.
Protein structure and variant hotspots
- Protein features: 4 domains; 6 binding sites; 1 post-translational modification sites.
- Structural context: 514 variants have structural context.
- PTM context: 2 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable ACTN2 variants
Examples include M1V, N2I, N2K, N2Y, N2S, N2N, Q3H, Q3R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1V (p.Met1Val), rs2527437803, ClinGen CA345358000, ClinVar RCV002642822, Uncertain significance, Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomyopathy
- N2I (p.Asn2Ile), cosmic curated COSV63972
- N2K (p.Asn2Lys), rs755508640, ClinGen CA1472692, ClinVar RCV001043519, ClinVar RCV005306234, REVEL 0.22, CADD 20.60, Uncertain significance, Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomyopathy
- N2Y (p.Asn2Tyr), gnomAD 1-236686677-A-T, REVEL 0.34, CADD 24.60
- N2S (p.Asn2Ser), gnomAD 1-236686678-A-G, REVEL 0.25, CADD 21.70
- N2N (p.Asn2Asn), gnomAD 1-236686679-C-T, CADD 13.60
- Q3H (p.Gln3His), rs1553295387, ClinGen CA345358060, ClinVar RCV000638631, Ensembl rs1553295387, REVEL 0.38, CADD 23.30, Uncertain significance, Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomyopathy
- Q3R (p.Gln3Arg), rs1665879577, ClinGen CA345358053, ClinVar RCV001302620, Ensembl rs1665879577, REVEL 0.37, CADD 23.20, Uncertain significance, Primary familial hypertrophic cardiomyopathy; Dilated cardiomyopathy 1AA
- Q3K (p.Gln3Lys), gnomAD 1-236686680-C-A, REVEL 0.31, CADD 22.40
- Q3L (p.Gln3Leu), gnomAD 1-236686681-A-T, REVEL 0.32, CADD 24.80
- I4K (p.Ile4Lys), gnomAD rs1482303680, REVEL 0.38, CADD 24.20
- I4M (p.Ile4Met), rs781720338, ClinGen CA1472693, ClinVar RCV001345001, ClinVar RCV005792095, REVEL 0.25, CADD 11.70, Uncertain significance, Cardiovascular phenotype; Primary familial hypertrophic cardiomyopathy; Dilated
- I4V (p.Ile4Val), gnomAD 1-236686683-A-G, REVEL 0.25, CADD 16.50
- I4L (p.Ile4Leu), gnomAD 1-236686683-A-T, REVEL 0.30, CADD 21.10
- I4T (p.Ile4Thr), gnomAD 1-236686684-T-C, REVEL 0.31, CADD 23.00
- I4R (p.Ile4Arg), gnomAD 1-236686684-T-G, REVEL 0.43, CADD 24.40
- E5K (p.Glu5Lys), gnomAD rs1255377980
- E5* (p.Glu5Ter), gnomAD 1-236686686-G-T, CADD 39.00
- E5Q (p.Glu5Gln), gnomAD 1-236686686-G-C, REVEL 0.33, CADD 23.30
- E5V (p.Glu5Val), gnomAD 1-236686687-A-T, REVEL 0.18, CADD 23.60
- E5G (p.Glu5Gly), gnomAD 1-236686687-A-G, REVEL 0.27, CADD 25.30
- E5D (p.Glu5Asp), gnomAD 1-236686688-G-T, REVEL 0.22, CADD 21.70
- E5E (p.Glu5Glu), gnomAD 1-236686688-G-A, CADD 14.00
- P6A (p.Pro6Ala), rs1428900516, ClinGen CA345358082, ClinVar RCV003788782, REVEL 0.21, CADD 20.50, Uncertain significance, Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomyopathy
- P6R (p.Pro6Arg), rs2102851212, ClinGen CA345358086, ClinVar RCV001974686, Ensembl rs2102851212, AlphaMissense 0.14, MetaLR 0.33, Uncertain significance, Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomyopathy
- P6S (p.Pro6Ser), rs1428900516, ClinGen CA345358083, ClinVar RCV003797984, TOPMed rs1428900516, REVEL 0.19, CADD 21.00, Uncertain significance, Primary familial hypertrophic cardiomyopathy; Dilated cardiomyopathy 1AA
- P6T (p.Pro6Thr), gnomAD 1-236686689-C-A, REVEL 0.20, CADD 19.70
- P6H (p.Pro6His), gnomAD 1-236686690-C-A, REVEL 0.30, CADD 23.90
- P6P (p.Pro6Pro), gnomAD 1-236686691-C-G, CADD 15.30
- G7D (p.Gly7Asp), Ensembl rs2102851232, REVEL 0.20, CADD 22.80
- G7S (p.Gly7Ser), rs1057523721, ClinGen CA16603593, ClinVar RCV000435130, ClinVar RCV000560681, REVEL 0.19, CADD 21.80, Uncertain significance, Primary familial hypertrophic cardiomyopathy; Dilated cardiomyopathy 1AA; Cardio
- G7A (p.Gly7Ala), gnomAD 1-236686688-GC-G, CADD 26.80
- G7C (p.Gly7Cys), gnomAD 1-236686692-G-T, REVEL 0.34, CADD 24.50
- G7G (p.Gly7Gly), rs1387972965, gnomAD 1-236686694-C-T, CADD 14.90
- V8L (p.Val8Leu), rs551141480, cosmic curated COSV63972, ClinGen CA345358093, ClinVar RCV002446310, REVEL 0.20, CADD 22.20, Uncertain significance, Cardiovascular phenotype
- V8M (p.Val8Met), rs551141480, ClinGen CA1472694, NCI-TCGA Cosmic COSV6397, REVEL 0.20, CADD 23.00, Likely benign, Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomyopathy; not sp
- V8A (p.Val8Ala), gnomAD 1-236686696-T-C, REVEL 0.19, CADD 22.90
- V8V (p.Val8Val), rs1665880874, gnomAD 1-236686697-G-A, CADD 14.60
- Q9* (p.Gln9Ter), gnomAD rs1665880953, CADD 38.00
- Q9K (p.Gln9Lys), gnomAD rs1665880953, REVEL 0.33, CADD 22.20
- Q9P (p.Gln9Pro), rs121434525, ClinGen CA345358101, ClinVar RCV002816606, ClinVar RCV004603237, AlphaMissense 0.11, MetaLR 0.23, Uncertain significance, Cardiovascular phenotype; Dilated cardiomyopathy 1AA; Primary familial hypertrop
- Q9R (p.Gln9Arg), rs121434525, ClinGen CA090885, cosmic curated COSV63972, ClinVar RCV000019977, REVEL 0.36, AlphaMissense 0.11, Conflicting interpretations, Dilated cardiomyopathy 1AA; Myopathy, congenital, with structured cores and z-li
- Q9S (p.Gln9Ser), gnomAD 1-236686696-TG-T, CADD 31.00
- Q9E (p.Gln9Glu), gnomAD 1-236686698-C-G, REVEL 0.26, CADD 20.30
- Q9H (p.Gln9His), gnomAD 1-236686700-G-T, REVEL 0.25, CADD 22.60
- Q9Q (p.Gln9Gln), rs1376810575, gnomAD 1-236686700-G-A, CADD 14.10
- Y10C (p.Tyr10Cys), gnomAD rs1464103836, REVEL 0.67, CADD 25.80
- Y10H (p.Tyr10His), gnomAD 1-236686701-T-C, REVEL 0.55, CADD 25.30
- Y10* (p.Tyr10Ter), gnomAD 1-236686703-C-A, CADD 37.00
- Y10Y (p.Tyr10Tyr), rs2102851277, gnomAD 1-236686703-C-T, CADD 13.90
- N11H (p.Asn11His), rs886046205, ClinGen CA10610583, ClinVar RCV000265212, ClinVar RCV002446540, REVEL 0.24, CADD 22.90, Uncertain significance, Dilated cardiomyopathy 1AA; Cardiovascular phenotype; Primary familial hypertrop
- N11S (p.Asn11Ser), rs1449856891, ClinGen CA345358117, ClinVar RCV001062961, ClinVar RCV004994228, REVEL 0.17, CADD 22.50, Uncertain significance, Cardiovascular phenotype; Primary familial hypertrophic cardiomyopathy; Dilated
- N11D (p.Asn11Asp), gnomAD 1-236686704-A-G, REVEL 0.18, CADD 22.50
- N11K (p.Asn11Lys), gnomAD 1-236686706-C-G, REVEL 0.16, CADD 23.20
- Y12* (p.Tyr12Ter), gnomAD rs1302783639, CADD 36.00, Likely benign
- Y12C (p.Tyr12Cys), rs1665881725, ClinGen CA345358131, ClinVar RCV002770319, ClinVar RCV003167746, REVEL 0.56, CADD 29.10, Uncertain significance, Cardiovascular phenotype; Dilated cardiomyopathy 1AA; Primary familial hypertrop
- Y12H (p.Tyr12His), gnomAD 1-236686707-T-C, REVEL 0.27, CADD 23.40
- Y12Y (p.Tyr12Tyr), rs1302783639, gnomAD 1-236686709-C-T, CADD 12.90
- V13L (p.Val13Leu), gnomAD rs1386246024, REVEL 0.21, CADD 22.70, Likely benign, Cardiovascular phenotype
- V13M (p.Val13Met), NCI-TCGA Cosmic COSV6397, cosmic curated COSV63976, REVEL 0.16, CADD 23.20, Variant assessed as somatic; moderate impact.
- V13A (p.Val13Ala), gnomAD 1-236686711-T-C, REVEL 0.18, CADD 22.30
- V13V (p.Val13Val), gnomAD 1-236686712-G-T, CADD 12.40
- Y14* (p.Tyr14Ter), NCI-TCGA Cosmic COSV6397, cosmic curated COSV63973, CADD 35.00, Variant assessed as somatic; high impact.
- Y14C (p.Tyr14Cys), rs1665882020, ClinGen CA345358165, ClinVar RCV003296759, Ensembl rs1665882020, REVEL 0.40, CADD 29.40, Uncertain significance, Cardiovascular phenotype
- Y14F (p.Tyr14Phe), cosmic curated COSV10085
- Y14H (p.Tyr14His), gnomAD 1-236686713-T-C, REVEL 0.38, CADD 23.50
- Y14Y (p.Tyr14Tyr), gnomAD 1-236686715-C-T, CADD 11.50
- D15A (p.Asp15Ala), TOPMed rs1181394258, gnomAD rs1181394258, REVEL 0.15, CADD 25.30
- D15E (p.Asp15Glu), ExAC rs771424965, TOPMed rs771424965, gnomAD rs771424965, REVEL 0.08, CADD 6.35
- D15H (p.Asp15His), cosmic curated COSV10529
- D15N (p.Asp15Asn), rs1242103284, ClinGen CA345358177, cosmic curated COSV63975, ClinVar RCV003379893, REVEL 0.13, CADD 25.20, Conflicting interpretations, Cardiovascular phenotype; Primary familial hypertrophic cardiomyopathy; Dilated
- D15del (p.Asp15del), rs771008376, gnomAD 1-236686713-TACG-, CADD 22.20
- D15Y (p.Asp15Tyr), gnomAD 1-236686716-G-T, REVEL 0.14, CADD 23.70
- D15G (p.Asp15Gly), gnomAD 1-236686717-A-G, REVEL 0.16, CADD 23.90
- D15D (p.Asp15Asp), gnomAD 1-236686718-C-T, CADD 8.35
- E16K (p.Glu16Lys), rs775052416, ClinGen CA1472697, ClinVar RCV003081618, ClinVar RCV004992485, REVEL 0.14, CADD 23.40, Conflicting interpretations, Primary familial hypertrophic cardiomyopathy; Dilated cardiomyopathy 1AA; Cardio
- E16* (p.Glu16Ter), gnomAD 1-236686719-G-T, CADD 38.00
- E16Q (p.Glu16Gln), gnomAD 1-236686719-G-C, REVEL 0.11, CADD 22.90
- E16G (p.Glu16Gly), gnomAD 1-236686720-A-G, REVEL 0.10, CADD 23.30
- E16D (p.Glu16Asp), gnomAD 1-236686721-G-T, REVEL 0.04, CADD 4.59
- E16E (p.Glu16Glu), rs397516580, gnomAD 1-236686721-G-A, CADD 6.18
- D17Y (p.Asp17Tyr), gnomAD rs1305880301, REVEL 0.12, CADD 23.70
- D17N (p.Asp17Asn), gnomAD 1-236686722-G-A, REVEL 0.08, CADD 23.50
- D17G (p.Asp17Gly), gnomAD 1-236686723-A-G, REVEL 0.12, CADD 26.30
- D17D (p.Asp17Asp), gnomAD 1-236686724-T-C, CADD 14.60
- E18A (p.Glu18Ala), rs1237522987, ClinGen CA345358223, ClinVar RCV001364947, TOPMed rs1237522987, AlphaMissense 0.14, MetaLR 0.18, Uncertain significance, Primary familial hypertrophic cardiomyopathy; Dilated cardiomyopathy 1AA
- E18D (p.Glu18Asp), ExAC rs768605809, gnomAD rs768605809, REVEL 0.10, CADD 16.40, Likely benign, Primary familial hypertrophic cardiomyopathy; Dilated cardiomyopathy 1AA
- E18G (p.Glu18Gly), TOPMed rs1237522987, gnomAD rs1237522987, REVEL 0.10, AlphaMissense 0.14, Uncertain significance
- E18* (p.Glu18Ter), gnomAD 1-236686725-G-T, CADD 38.00
- E18E (p.Glu18Glu), gnomAD 1-236686727-G-A, CADD 13.60
- Y19C (p.Tyr19Cys), rs2527438206, ClinGen CA345358235, ClinVar RCV002829106, REVEL 0.42, CADD 32.00, Uncertain significance, Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomyopathy
- Y19T (p.Tyr19Thr), gnomAD 1-236686727-GT-G, CADD 31.00
- Y19H (p.Tyr19His), gnomAD 1-236686728-T-C, REVEL 0.28, CADD 23.80
- Y19N (p.Tyr19Asn), gnomAD 1-236686728-T-A, REVEL 0.34, CADD 23.90
- Y19* (p.Tyr19Ter), gnomAD 1-236686730-C-A, CADD 36.00
- Y19Y (p.Tyr19Tyr), gnomAD 1-236686730-C-T, CADD 13.20
- M20T (p.Met20Thr), rs776456711, ClinGen CA1472699, ClinVar RCV001374171, ClinVar RCV001806160, REVEL 0.34, CADD 23.00, Uncertain significance, Myopathy, congenital, with structured cores and z-line abnormalities; Myopathy
- M20V (p.Met20Val), rs1203291298, ClinGen CA345358241, ClinVar RCV002355676, ClinVar RCV006559079, REVEL 0.28, CADD 23.10, Uncertain significance, Cardiovascular phenotype; Dilated cardiomyopathy 1AA; Primary familial hypertrop
- M20K (p.Met20Lys), gnomAD 1-236686732-T-A, REVEL 0.40, CADD 25.20
- M20I (p.Met20Ile), gnomAD 1-236686733-G-T, REVEL 0.34, CADD 25.00
- I21L (p.Ile21Leu), cosmic curated COSV63971
- I21M (p.Ile21Met), NCI-TCGA Cosmic COSV6397, cosmic curated COSV63976, Variant assessed as somatic; moderate impact.
- I21T (p.Ile21Thr), rs2527438243, ClinVar RCV004576054, ClinVar RCV005220953, REVEL 0.09, CADD 22.40, Uncertain significance, Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomyopathy; not pr
- I21V (p.Ile21Val), gnomAD 1-236686734-A-G, REVEL 0.10, CADD 19.60
- I21F (p.Ile21Phe), gnomAD 1-236686734-A-T, REVEL 0.10, CADD 22.40
- I21I (p.Ile21Ile), gnomAD 1-236686736-C-A, CADD 14.90
- Q22* (p.Gln22Ter), rs1553295414, ClinGen CA345358257, ClinVar RCV000527174, Ensembl rs1553295414, CADD 37.00, Uncertain significance
- Q22L (p.Gln22Leu), rs1057518609, ClinGen CA16042379, ClinVar RCV000413316, ClinVar RCV002524660, AlphaMissense 0.43, MetaLR 0.28, Uncertain significance, Primary familial hypertrophic cardiomyopathy; Dilated cardiomyopathy 1AA; not pr
- Q22R (p.Gln22Arg), rs1057518609, ClinGen CA345358259, ClinVar RCV003057525, REVEL 0.30, AlphaMissense 0.43, Uncertain significance, Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomyopathy
- Q22K (p.Gln22Lys), gnomAD 1-236686737-C-A, REVEL 0.25, CADD 23.80
- Q22H (p.Gln22His), gnomAD 1-236686739-G-T, REVEL 0.26, CADD 25.60
- Q22Q (p.Gln22Gln), rs761544833, gnomAD 1-236686739-G-A, CADD 13.60
- E23K (p.Glu23Lys), cosmic curated COSV10529
- E23Q (p.Glu23Gln), rs1229509268, ClinGen CA345358263, ClinVar RCV003040061, Ensembl rs1229509268, REVEL 0.15, CADD 22.70, Uncertain significance, Primary familial hypertrophic cardiomyopathy; Dilated cardiomyopathy 1AA
- E23* (p.Glu23Ter), gnomAD 1-236686740-G-T, CADD 37.00
- E23G (p.Glu23Gly), gnomAD 1-236686741-A-G, REVEL 0.26, CADD 25.10
- E23E (p.Glu23Glu), gnomAD 1-236686742-G-A, CADD 13.10
- E23D (p.Glu23Asp), gnomAD 1-236686742-G-T, REVEL 0.10, CADD 20.40
- E24D (p.Glu24Asp), gnomAD rs1189880689, REVEL 0.05, CADD 19.40
- E24G (p.Glu24Gly), cosmic curated COSV10085, REVEL 0.27, CADD 26.80
- E24E (p.Glu24Glu), gnomAD 1-236686745-G-A, CADD 14.10
- E25del (p.Glu25del), rs1255354051, gnomAD 1-236686737-CAGG-, CADD 22.20
- E25K (p.Glu25Lys), gnomAD 1-236686746-G-A, REVEL 0.31, CADD 26.60
- E25* (p.Glu25Ter), gnomAD 1-236686746-G-T, CADD 40.00
- E25G (p.Glu25Gly), gnomAD 1-236686747-A-G, REVEL 0.25, CADD 24.90
- E25E (p.Glu25Glu), rs1210479277, gnomAD 1-236686748-G-A, CADD 13.10
- W26L (p.Trp26Leu), NCI-TCGA TCGA novel, REVEL 0.49, CADD 32.00, Variant assessed as somatic; high impact.
- W26R (p.Trp26Arg), gnomAD 1-236686749-T-A, REVEL 0.48, CADD 24.60
- W26* (p.Trp26Ter), gnomAD 1-236686750-G-A, CADD 40.00
- W26C (p.Trp26Cys), gnomAD 1-236686751-G-T, REVEL 0.53, CADD 32.00
- D27N (p.Asp27Asn), ExAC rs765471221, gnomAD rs765471221, REVEL 0.21, CADD 24.10
- D27G (p.Asp27Gly), gnomAD 1-236686753-A-G, REVEL 0.46, CADD 24.20
- D27V (p.Asp27Val), gnomAD 1-236686753-A-T, REVEL 0.46, CADD 24.10
- D27D (p.Asp27Asp), gnomAD 1-236686754-C-T, CADD 15.40
- D27E (p.Asp27Glu), gnomAD 1-236686754-C-A, REVEL 0.11, CADD 22.70
- R28C (p.Arg28Cys), rs730880040, ClinGen CA346149, ClinVar RCV000157095, ClinVar RCV003764986, REVEL 0.49, CADD 32.00, Uncertain significance, Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomyopathy
- R28S (p.Arg28Ser), rs730880040, ClinGen CA345358324, ClinVar RCV002244439, gnomAD rs730880040, REVEL 0.41, CADD 24.70, Uncertain significance, not provided
- R28L (p.Arg28Leu), gnomAD 1-236686756-G-T, REVEL 0.47, CADD 32.00
- R28H (p.Arg28His), gnomAD 1-236686756-G-A, REVEL 0.36, CADD 27.10
- R28R (p.Arg28Arg), gnomAD 1-236686757-C-A, CADD 15.10
- D29G (p.Asp29Gly), gnomAD rs1193949299, REVEL 0.28, CADD 26.10
- D29N (p.Asp29Asn), rs750574123, ClinGen CA1472702, cosmic curated COSV63976, ClinVar RCV002291978, REVEL 0.25, CADD 26.50, Uncertain significance, not provided; Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomy
- D29H (p.Asp29His), gnomAD 1-236686758-G-C, REVEL 0.34, CADD 32.00
- D29Y (p.Asp29Tyr), gnomAD 1-236686758-G-T, REVEL 0.40, CADD 32.00
- D29E (p.Asp29Glu), gnomAD 1-236686760-C-G, REVEL 0.06, CADD 19.10
- D29D (p.Asp29Asp), rs763227511, gnomAD 1-236686760-C-T, CADD 15.10
- L30M (p.Leu30Met), gnomAD 1-236686761-C-A, REVEL 0.07, CADD 22.60
- L30L (p.Leu30Leu), gnomAD 1-236686761-C-T, CADD 15.30
- L30P (p.Leu30Pro), gnomAD 1-236686762-T-C, REVEL 0.28, CADD 25.80
- L31I (p.Leu31Ile), gnomAD 1-236686764-C-A, REVEL 0.13, CADD 24.10
- L31P (p.Leu31Pro), gnomAD 1-236686765-T-C, REVEL 0.39, CADD 24.30
- L31L (p.Leu31Leu), rs397516586, gnomAD 1-236686766-C-T, CADD 10.20
- L32M (p.Leu32Met), NCI-TCGA TCGA novel, REVEL 0.23, CADD 25.10, Variant assessed as somatic; moderate impact.
- L32L (p.Leu32Leu), gnomAD 1-236686767-C-T, CADD 14.50
- L32P (p.Leu32Pro), gnomAD 1-236686768-T-C, REVEL 0.60, CADD 32.00
- D33Y (p.Asp33Tyr), cosmic curated COSV63971, REVEL 0.54, CADD 32.00
- D33G (p.Asp33Gly), gnomAD 1-236686771-A-G, REVEL 0.47, CADD 26.00
- D33V (p.Asp33Val), gnomAD 1-236686771-A-T, REVEL 0.57, CADD 31.00
- D33E (p.Asp33Glu), gnomAD 1-236686772-C-A, REVEL 0.16, CADD 23.30
- D33D (p.Asp33Asp), gnomAD 1-236686772-C-T, CADD 14.70
- P34Q (p.Pro34Gln), gnomAD 1-236686771-AC-A, CADD 26.90
- P34T (p.Pro34Thr), gnomAD 1-236686773-C-A, REVEL 0.35, CADD 23.80
- P34S (p.Pro34Ser), gnomAD 1-236686773-C-T, REVEL 0.33, CADD 24.30
- P34L (p.Pro34Leu), gnomAD 1-236686774-C-T, REVEL 0.39, CADD 24.70
- P34R (p.Pro34Arg), gnomAD 1-236686774-C-G, REVEL 0.41, CADD 24.60
- P34P (p.Pro34Pro), gnomAD 1-236686775-A-G, CADD 8.11
- A35D (p.Ala35Asp), TOPMed rs1665885927, REVEL 0.31, CADD 24.60
- A35S (p.Ala35Ser), cosmic curated COSV63971, REVEL 0.17, CADD 24.60
- A35T (p.Ala35Thr), rs2527438420, ClinGen CA345358406, ClinVar RCV003808791, REVEL 0.20, CADD 25.50, Uncertain significance, Primary familial hypertrophic cardiomyopathy; Dilated cardiomyopathy 1AA
- A35V (p.Ala35Val), gnomAD 1-236686777-C-T, REVEL 0.19, CADD 24.70
- A35A (p.Ala35Ala), gnomAD 1-236686778-C-T, CADD 16.10
- W36* (p.Trp36Ter), rs2102851395, ClinGen CA345358429, cosmic curated COSV63972, ClinVar RCV001508963, CADD 43.00, Uncertain significance
- W36R (p.Trp36Arg), gnomAD 1-236686779-T-C, REVEL 0.48, CADD 31.00
- W36L (p.Trp36Leu), gnomAD 1-236686780-G-T, REVEL 0.46, CADD 32.00
- W36C (p.Trp36Cys), gnomAD 1-236686781-G-T, REVEL 0.52, CADD 33.00
- E37K (p.Glu37Lys), TOPMed rs1313122387, gnomAD rs1313122387, REVEL 0.31, CADD 25.00
- E37R (p.Glu37Arg), gnomAD 1-236686779-TG-T, CADD 33.00
- E37* (p.Glu37Ter), gnomAD 1-236686782-G-T, CADD 39.00
- E37G (p.Glu37Gly), gnomAD 1-236686783-A-G, REVEL 0.44, CADD 32.00
- E37D (p.Glu37Asp), gnomAD 1-236686784-G-T, REVEL 0.10, CADD 23.10
Public ACTN2 analysis runs
- ACTN2 analysis run — ACTN2 (1,713 variants) — completed 2026-08-18